Consolidated Statements of Operations | |||||
(in thousands, except share data) |
|
|
| ||
|
Nine Months ended |
Three Months ended |
Year ended | ||
|
September 30, |
September 30, |
December 31, | ||
|
2014 |
2013 |
2014 |
2013 |
2013 |
|
U.S. dollars |
U.S. dollars |
U.S. dollars | ||
|
|
|
|
|
|
Revenues |
67,713 |
62,072 |
22,443 |
21,733 |
85,405 |
Cost of revenues |
36,146 |
34,363 |
12,474 |
12,046 |
51,003 |
|
|
|
|
|
|
Gross profit |
31,567 |
27,709 |
9,969 |
9,687 |
34,402 |
|
|
|
|
|
|
|
|
|
|
|
|
Research and development costs |
10,705 |
10,715 |
3,741 |
3,507 |
14,370 |
Selling, general and administrative expenses |
16,086 |
15,554 |
5,186 |
5,580 |
22,362 |
Reorganization and impairment |
- |
- |
- |
- |
(3,466) |
|
26,791 |
26,269 |
8,927 |
9,087 |
33,266 |
|
|
|
|
|
|
Operating income |
4,776 |
1,440 |
1,042 |
600 |
1,136 |
|
|
|
|
|
|
Financial expenses (income), net |
(861) |
(1,681) |
(167) |
(603) |
1,738 |
|
|
|
|
|
|
Income (loss) before income |
|
|
|
|
|
taxes |
3,915 |
(241) |
875 |
(3) |
(602) |
|
|
|
|
|
|
Income tax |
(646) |
(412) |
(257) |
(119) |
609 |
|
|
|
|
|
|
Net income (loss) |
3,269 |
(653) |
618 |
(122) |
7 |
|
|
|
|
|
|
Net income (loss) per ordinary share: |
|
|
|
|
|
|
|
|
|
|
|
Basic |
0.11 |
(0.02) |
0.02 |
0.00 |
0.00 |
|
|
|
|
|
|
Diluted |
0.11 |
(0.02) |
0.02 |
0.00 |
0.00 |
|
|
|
|
|
|
Weighted average number of |
|
|
|
|
|
ordinary shares outstanding: |
|
|
|
|
|
|
|
|
|
|
|
Basic |
30,457 |
29,993 |
30,476 |
30,046 |
30,040 |
|
|
|
|
|
|
Diluted |
30,542 |
29,993 |
30,556 |
30,046 |
30,044 |